More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of ...

BCS: MarginProbe Reduces Re-Excision Rate Post-Lumpectomy A novel device that emits an electric field and detects cancerous tissue from its characteristic returning signal, known as MarginProbe, may ...

A biosignature tool helps women avoid unnecessary radiotherapy after undergoing lumpectomy for ductal carcinoma in situ (DCIS) ― and also identifies women who need more intense treatment. The ...

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...

Breast cancer is hard enough. Treatment should be quick and easy. That's the thinking of many physicians who have opted to offer MammoSite, a type of radiation that cuts treatment time from several ...

TARGIT-IORT is a single dose of targeted radiation delivered from inside the breast during surgery immediately following the removal of the tumor while the patient remains asleep. SACRAMENTO, Calif., ...

Phase I study of vinorelbine (VRL) alternating i.v. and oral in combination with docetaxel (DTX) as 1st line chemotherapy (CT) of metastatic breast cancer (MBC) No significant financial relationships ...

“You know that phrase, ‘third time’s the charm?’ ” Marilene Nevins asks. Well, not always. In 1997, a suspicious mass was found in Nevins’ right breast. “I nicknamed that one Mickey,” she says. “You ...

Chemotherapy and radiotherapy should be given at the same time following a lumpectomy in order to minimise the risk of breast cancer relapsing, a new study says. Subscribe today for unlimited access ...

An Oct. 19 Health article about Mammosite, a new radiation treatment for breast cancer, listed an incorrect phone number for Holy Cross Hospital, which offers the treatment. The correct number is ...

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today ...